Henrik S. Andersen

Person

Bagsvaerd, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Antagonistic DR3 ligands
- Patent number 9,737,612
- Issue date Aug 22, 2017
- Novo Nordisk A/S
- Mette Dahl Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic DR3 ligands
- Patent number 9,713,644
- Issue date Jul 25, 2017
- Novo Nordisk A/S
- Mette Dahl Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Growth hormones with prolonged in-vivo efficacy
- Patent number 9,695,226
- Issue date Jul 4, 2017
- Novo Nordisk Healthcare AG
- Carsten Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Conjugated proteins with prolonged in vivo efficacy
- Patent number 8,865,868
- Issue date Oct 21, 2014
- Novo Nordisk Healthcare AG
- Carsten Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Growth hormones with prolonged in-vivo efficacy
- Patent number 8,841,249
- Issue date Sep 23, 2014
- Novo Nordisk A/S
- Nils Langeland Johansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Growth hormones with prolonged in-vivo efficacy
- Patent number 8,779,109
- Issue date Jul 15, 2014
- Novo Nordisk Health Care AG
- Carsten Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic DR3 ligands
- Patent number 8,765,130
- Issue date Jul 1, 2014
- Novo Nordisk A/S
- Mette Dahl Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
11-beta-hydroxysteroid dehydrogenase type 1 active compounds
- Patent number 8,383,668
- Issue date Feb 26, 2013
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical use of substituted amides
- Patent number 8,383,683
- Issue date Feb 26, 2013
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole- and benzimidazole amides as hydroxysteroid dehydrogenase in...
- Patent number 8,153,798
- Issue date Apr 10, 2012
- High Point Pharmaceuticals, LLC
- John Paul Kilburn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
- Patent number 8,138,342
- Issue date Mar 20, 2012
- High Point Pharmacueticals, LLC
- John Paul Kilburn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
11β-hydroxysteroid dehydrogenase type 1 active compounds
- Patent number 8,053,447
- Issue date Nov 8, 2011
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical use of substituted amides
- Patent number 8,053,431
- Issue date Nov 8, 2011
- High Point Pharmaceuticals, LLC
- John Paul Kilburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
11β-hydroxysteroid dehydrogenase type 1 active compounds
- Patent number 8,048,908
- Issue date Nov 1, 2011
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pharmaceutical use of fused 1,2,4-triazoles
- Patent number 7,723,323
- Issue date May 25, 2010
- High Point Pharmaceuticals, LLC
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
11β-hydroxysteroid dehydrogenase type 1 active compounds
- Patent number 7,700,583
- Issue date Apr 20, 2010
- High Point Pharmaceuticals, LLC
- Anette Gundertofte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy using an 11β-hydroxysteroid dehydrogenase type...
- Patent number 7,501,405
- Issue date Mar 10, 2009
- High Point Pharmaceuticals, LLC
- Gita Camilla Tejlgaard Kampen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical use of fused 1,2,4-triazoles
- Patent number 7,358,238
- Issue date Apr 15, 2008
- Novo Nordisk A/S
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell...
- Patent number 7,115,624
- Issue date Oct 3, 2006
- Novo Nordisk A/S
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of Protein Tyrosine Phosphatases (PTPases)
- Patent number 7,019,026
- Issue date Mar 28, 2006
- Novo Nordisk A/S
- Henrik Sune Andersen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of p...
- Patent number 6,951,878
- Issue date Oct 4, 2005
- Novo Nordisk A/S
- Niels Peter Hundahl Møller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dose setting device
- Patent number 6,796,970
- Issue date Sep 28, 2004
- Novo Nordisk A/S
- Lars Peter Klitmose
- B05 - SPRAYING OR ATOMISING IN GENERAL APPLYING LIQUIDS OR OTHER FLUENT MATER...
Information Patent Grant
Modulators of protein tyrosine phosphatases (PTPases)
- Patent number 6,613,903
- Issue date Sep 2, 2003
- Novo Nordisk A/S
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-substituted azaheterocyclic carboxylic acids and their use
- Patent number 6,613,791
- Issue date Sep 2, 2003
- Novo Nordisk A/S
- Florenzio Zaragossa Dörwald
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of protein tyrosine phosphatases (PTPases)
- Patent number 6,410,586
- Issue date Jun 25, 2002
- Novo Nordisk A/S
- Niels Peter Hundahl Møller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of protein tyrosine phosphateses (PTPases)
- Patent number 6,410,556
- Issue date Jun 25, 2002
- Novo Nordisk A/S
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of protein tyrosine phosphatases (PTPASES)
- Patent number 6,262,044
- Issue date Jul 17, 2001
- Novo Nordisk A/S
- Niels Peter Hundahl Møller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted azaheterocyclic carboxylic acids and esters thereof
- Patent number 6,239,148
- Issue date May 29, 2001
- Novo Nordisk A/S
- Florenzio Zaragossa Dörwald
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of protein tyrosine phosphatases (PTPases)
- Patent number 6,225,329
- Issue date May 1, 2001
- Novo Nordisk A/S
- Lutz Stefan Richter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of protein tyrosine phosphatases (PTPases)
- Patent number 6,169,087
- Issue date Jan 2, 2001
- Novo Nordisk A/S
- Henrik Sune Andersen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20200306382
- Publication date Oct 1, 2020
- Novo Nordisk Healthcare AG
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20200102568
- Publication date Apr 2, 2020
- Novo Nordisk Healthcare AG
- Carsten Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20190203213
- Publication date Jul 4, 2019
- Novo Nordisk Healthcare AG
- Carsten Behrens
- G01 - MEASURING TESTING
Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20180221501
- Publication date Aug 9, 2018
- Novo Nordisk Healthcare AG
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antagonistic DR3 Ligands
- Publication number 20170305994
- Publication date Oct 26, 2017
- Novo Nordisk A/S
- Mette Dahl Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20170239362
- Publication date Aug 24, 2017
- Novo Nordisk Healthcare AG
- Carsten Behrens
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE
- Publication number 20150273027
- Publication date Oct 1, 2015
- Novo Nordisk Healthcare AG
- Prafull S. Gandhi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20140329750
- Publication date Nov 6, 2014
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC DR3 LIGANDS
- Publication number 20140294853
- Publication date Oct 2, 2014
- Novo Nordisk A/S
- Mette Dahl Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20140107324
- Publication date Apr 17, 2014
- Novo Nordisk Health Care AG
- Carsten Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC DR3 LIGANDS
- Publication number 20130336984
- Publication date Dec 19, 2013
- Novo Nordisk A/S
- Mette Dahl Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONISTIC DR3 LIGANDS
- Publication number 20130330360
- Publication date Dec 12, 2013
- Novo Nordisk A/S
- Mette Dahl Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GROWTH HORMONE CONJUGATES
- Publication number 20130143815
- Publication date Jun 6, 2013
- Novo Nordisk Health Care AG
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormones With Prolonged In-Vivo Efficacy
- Publication number 20120309944
- Publication date Dec 6, 2012
- Novo Nordisk Health Care AG
- Carsten Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Growth Hormones with Prolonged In-Vivo Efficacy
- Publication number 20120172303
- Publication date Jul 5, 2012
- Novo Nordisk Health Care AG
- Nils Langeland Johansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
- Publication number 20120010194
- Publication date Jan 12, 2012
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Application
11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
- Publication number 20120004209
- Publication date Jan 5, 2012
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL USE OF SUBSTITUTED AMIDES
- Publication number 20110312949
- Publication date Dec 22, 2011
- High Point Pharmaceuticals, LLC
- John Paul Kilburn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATED PROTEINS WITH PROLONGED IN VIVO EFFICACY
- Publication number 20110223151
- Publication date Sep 15, 2011
- Novo Nordisk Health Care AG
- Carsten Behrens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
- Publication number 20100292215
- Publication date Nov 18, 2010
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL USE OF FUSED 1,2,4-TRIAZOLES
- Publication number 20100197658
- Publication date Aug 5, 2010
- High Point Pharmaceuticals, LLC
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
- Publication number 20100120743
- Publication date May 13, 2010
- High Point Pharmaceuticals, LLC
- Anette Gundertofte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL USE OF SUBSTITUTED AMIDES
- Publication number 20100087543
- Publication date Apr 8, 2010
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLE- AND BENZIMIDAZOLE AMIDES AS HYDROXYSTEROID DEHYDROGENASE IN...
- Publication number 20100076041
- Publication date Mar 25, 2010
- John Paul Kilburn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
11BETA-HSD1 ACTIVE COMPOUNDS
- Publication number 20100056600
- Publication date Mar 4, 2010
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Application
11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
- Publication number 20100009968
- Publication date Jan 14, 2010
- High Point Pharmaceuticals, LLC
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-PIPERIDYLBENZAMIDES AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE...
- Publication number 20090325932
- Publication date Dec 31, 2009
- Soren Ebdrup
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL USE OF SUBSTITUTED PIPERIDINE CARBOXAMIDES
- Publication number 20090306048
- Publication date Dec 10, 2009
- John Paul Kilburn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Ty...
- Publication number 20090264412
- Publication date Oct 22, 2009
- High Point Pharmaceuticals, LLC
- Gita Camilla Tejlgaard Kampen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Amide Derivatives and Pharmaceutical Use Thereof
- Publication number 20090264414
- Publication date Oct 22, 2009
- High Point Pharmaceuticals, LLC
- Henrik Sune Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Henrik S. Andersen

Person

Patents Grantslast 30 patents

Antagonistic DR3 ligands

Antagonistic DR3 ligands

Growth hormones with prolonged in-vivo efficacy

Conjugated proteins with prolonged in vivo efficacy

Growth hormones with prolonged in-vivo efficacy

Growth hormones with prolonged in-vivo efficacy

Antagonistic DR3 ligands

11-beta-hydroxysteroid dehydrogenase type 1 active compounds

Pharmaceutical use of substituted amides

Indole- and benzimidazole amides as hydroxysteroid dehydrogenase in...

11β-hydroxysteroid dehydrogenase type 1 active spiro compounds

11β-hydroxysteroid dehydrogenase type 1 active compounds

Pharmaceutical use of substituted amides

11β-hydroxysteroid dehydrogenase type 1 active compounds

Pharmaceutical use of fused 1,2,4-triazoles

11β-hydroxysteroid dehydrogenase type 1 active compounds

Combination therapy using an 11β-hydroxysteroid dehydrogenase type...

Pharmaceutical use of fused 1,2,4-triazoles

Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell...

Modulators of Protein Tyrosine Phosphatases (PTPases)

Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of p...

Dose setting device

Modulators of protein tyrosine phosphatases (PTPases)

N-substituted azaheterocyclic carboxylic acids and their use

Modulators of protein tyrosine phosphatases (PTPases)

Modulators of protein tyrosine phosphateses (PTPases)

Modulators of protein tyrosine phosphatases (PTPASES)

N-substituted azaheterocyclic carboxylic acids and esters thereof

Modulators of protein tyrosine phosphatases (PTPases)

Modulators of protein tyrosine phosphatases (PTPases)

Patents Applicationslast 30 patents

Growth Hormones with Prolonged In-Vivo Efficacy

Growth Hormones with Prolonged In-Vivo Efficacy

Growth Hormones with Prolonged In-Vivo Efficacy

Growth Hormones with Prolonged In-Vivo Efficacy

Antagonistic DR3 Ligands

Growth Hormones with Prolonged In-Vivo Efficacy

LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE

Growth Hormones with Prolonged In-Vivo Efficacy

ANTAGONISTIC DR3 LIGANDS

Growth Hormones with Prolonged In-Vivo Efficacy

ANTAGONISTIC DR3 LIGANDS

ANTAGONISTIC DR3 LIGANDS

GROWTH HORMONE CONJUGATES

Growth Hormones With Prolonged In-Vivo Efficacy

Growth Hormones with Prolonged In-Vivo Efficacy

11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds

11-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds

PHARMACEUTICAL USE OF SUBSTITUTED AMIDES

CONJUGATED PROTEINS WITH PROLONGED IN VIVO EFFICACY

11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS

PHARMACEUTICAL USE OF FUSED 1,2,4-TRIAZOLES

11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds

PHARMACEUTICAL USE OF SUBSTITUTED AMIDES

INDOLE- AND BENZIMIDAZOLE AMIDES AS HYDROXYSTEROID DEHYDROGENASE IN...

11BETA-HSD1 ACTIVE COMPOUNDS

11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS

4-PIPERIDYLBENZAMIDES AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE...

PHARMACEUTICAL USE OF SUBSTITUTED PIPERIDINE CARBOXAMIDES

Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Ty...

Amide Derivatives and Pharmaceutical Use Thereof